Tracker › Companies › GSK (Belgium)
25 Probably not mainly AI. The paper trail for GSK (Belgium)'s cuts points mostly elsewhere, with only a faint AI signal.
Every tracked 2026 layoff at GSK (Belgium), newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 25/100 (Low) · 80% interval 21–28 · evidence grade C · UK · Pharmaceutical
Stated reason: Belgian office and managerial roles cut in a 3-year global cost programme reallocating to priority medicines; digitalisation and automation planned.
Why 25: Plan mentions automation/digitalization generally (not AI-specific); also: Cost-cutting / efficiency · Drivers: AI attribution +1.7, industry AI exposure +0.5
Evidence: major-outlet report. Signals: attribution 0.35, primary source 0.0, exec statement 0.0, role exposure 0.653, industry exposure 0.712, AI investment 0.0, contrary evidence 0.0 · typical Health Care & Pharma roles (no roles named)
Headcount basis: announced
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 1,037 workers
Health Care & Pharma · 4,500 workers
Health Care & Pharma · 718 workers
Health Care & Pharma · 628 workers
Health Care & Pharma · 278 workers
Health Care & Pharma · 145 workers
